(May 3, 2016, 2:00 PM EDT) -- WASHINGTON, D.C. — Three union health care funds on April 29 told the U.S. Supreme Court that it should deny review of their Racketeer Influenced and Corrupt Organizations Act case involving the diabetes drug Avandia because the third-party payers are suing over the same behavior to which defendant GlaxoSmithKline LLC (GSK) has pleaded guilty (GlaxoSmithKline LLC v. Allied Services Division Welfare Fund, et al., No. 15-1078, U.S. Sup.)....